These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32540145)

  • 21. The Placenta as a Window to Maternal Vascular Health.
    Parks WT; Catov JM
    Obstet Gynecol Clin North Am; 2020 Mar; 47(1):17-28. PubMed ID: 32008667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the link between the placenta and future cardiovascular disease.
    Siddiqui N; Hladunewich M
    Trends Cardiovasc Med; 2011 Oct; 21(7):188-93. PubMed ID: 22867697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saturated fat-rich diet increases fetal lipids and modulates LPL and leptin receptor expression in rat placentas.
    Mazzucco MB; Higa R; Capobianco E; Kurtz M; Jawerbaum A; White V
    J Endocrinol; 2013 Jun; 217(3):303-15. PubMed ID: 23482704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health.
    Staff AC; Dechend R; Pijnenborg R
    Hypertension; 2010 Dec; 56(6):1026-34. PubMed ID: 20956732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinico-morphological parallels between the condition of the fetus and the newborn and changes in the placenta during hypertensive disease].
    Pivenshteĭn VD
    Vopr Okhr Materin Det; 1968 Aug; 13(8):65-70. PubMed ID: 5712206
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxidative stress in placental pathology.
    Schoots MH; Gordijn SJ; Scherjon SA; van Goor H; Hillebrands JL
    Placenta; 2018 Sep; 69():153-161. PubMed ID: 29622278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrauterine effects of impaired lipid homeostasis in pregnancy diseases.
    Higa R; Jawerbaum A
    Curr Med Chem; 2013; 20(18):2338-50. PubMed ID: 23521676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphometric evaluation.
    Teasdale F
    Contrib Gynecol Obstet; 1982; 9():17-28. PubMed ID: 7140298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology.
    Reiter RJ; Tan DX; Korkmaz A; Rosales-Corral SA
    Hum Reprod Update; 2014; 20(2):293-307. PubMed ID: 24132226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and maternal-fetal conflict during placental malaria.
    Muehlenbachs A; Mutabingwa TK; Edmonds S; Fried M; Duffy PE
    PLoS Med; 2006 Nov; 3(11):e446. PubMed ID: 17105340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal vasculopathy and histologic diagnosis of preeclampsia: poor correlation of histologic changes and clinical manifestation.
    Zhang P; Schmidt M; Cook L
    Am J Obstet Gynecol; 2006 Apr; 194(4):1050-6. PubMed ID: 16580295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment and management of cardiac disease in pregnancy.
    Davies GAL; Herbert WNP
    J Obstet Gynaecol Can; 2007 Apr; 29(4):331-336. PubMed ID: 17475126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Placental features in intrauterine growth retardation].
    Marcorelles P
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):996-1007. PubMed ID: 24210718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Models of Cardiovascular Diseases: Overview.
    Oh JG; Ishikawa K
    Methods Mol Biol; 2018; 1816():3-14. PubMed ID: 29987807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into cardiovascular risk and nutritional status in subjects with wheat-related disorders.
    Siriwardhane T; Krishna K; Devarajan K; Ranganathan V; Jayaraman V; Wang T; Bei K; Rajasekaran JJ; Krishnamurthy H
    Biomarkers; 2019 May; 24(3):303-307. PubMed ID: 30734586
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study of dopplerometry and morphological study of placenta and uterine arteries in the evaluation of hemodynamic disorders in the "mother-placenta-fetus" system].
    Strazhakov AN; Bunin AT; Medvedev MV; Ageeva MI; Milovanov AP; Kadyrov MK; Voloshchuk IN
    Akush Ginekol (Mosk); 1991 Mar; (3):24-9. PubMed ID: 2058770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on pregnancy hypertension and IUGR-SFD: effects of drugs on the blood vessels in the placenta of pregnant SHRSP.
    Fuchi I; Noda K; Matsubara Y
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S286-7. PubMed ID: 9072394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered cord blood lipid profile, insulin resistance & growth restriction during the perinatal period & its potential role in the risk of developing cardiovascular disease later in life.
    Tank S; Jain SK
    Indian J Med Res; 2016 Aug; 144(2):151-153. PubMed ID: 27934793
    [No Abstract]   [Full Text] [Related]  

  • 39. [Morphology of the placenta in several forms of obstetric pathology].
    Veksler DB
    Akush Ginekol (Mosk); 1967 Oct; 43(10):51-5. PubMed ID: 5617283
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoprotein Profile Modifications during Gestation: A Current Approach to Cardiovascular risk surrogate markers and Maternal-fetal Unit Complications.
    Santos APCD; Couto RD
    Rev Bras Ginecol Obstet; 2018 May; 40(5):281-286. PubMed ID: 29768640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.